10 Cambridge spinouts changing the story of cancer
17 October 202410 Cambridge spinouts on putting their research into practice to improve outcomes for cancer patients - and why Cambridge is a great place to do this.
10 Cambridge spinouts on putting their research into practice to improve outcomes for cancer patients - and why Cambridge is a great place to do this.
A common class of chemicals found everywhere from car exhausts, smoke, building materials and furniture to cosmetics and shampoos could increase cancer risk because of their ability to break down the repair mechanisms that prevent faults in our genes, according to a study published today in the journal Cell.
Almost one in four of the world’s cases of tuberculosis (TB) are in India and the disease is constantly adapting itself to outwit our medicines. Could the answer lie in targeting not the bacteria but its host, the patient?
Cancer will affect one in three of us at some point in our lives, so research into this disease is vital. Most cancer patients will see their doctor when the disease is already advanced and harder to treat, according to Professor Ashok Venkitaraman, Director of the Medical Research Council (MRC) Cancer Unit in Cambridge.
Fundamental research is pioneering innovative approaches to cancer diagnosis and treatment at the Hutchison/MRC Research Centre.
A new Cambridge programme aims to meet the challenges of drug discovery by harnessing a spectrum of academic expertise.